MEGGLE presents excipient blending insights at RDD USA

Wasserburg, Germany: – Pharmaceutical lactose specialist MEGGLE will attend the 2024 USA Respiratory Drug Delivery (RDD) conference in Tucson, Arizona, with prominent presence as a sponsor, exhibitor and work shop presenter contributing insights into blending multi-component dry powder inhalation formulations.

Subject to confirmation, MEGGLE will exhibit from Table 10 within the Inspiring Dry Powder Inhalation Knowledge Space at the JW Marriott Starr Pass conference venue in Tucson. MEGGLE’s R&D team will display the extensive portfolio of InhaLac®, high quality crystalline lactose-based DPI excipients, which are specifically designed to support DPI formulations. These sieved, milled and micronized lactose monohydrates are presented in a wide range of particle sizes and are particularly suitable for use in pulmonary dry powder inhalers and nasal drug delivery systems.

Workshop host

MEGGLE will host a workshop on the symposium’s Day Three with a presentation on ‘Blending Optimization in Multi-component DPI Formulations’ (Arizona Salon 4, May 7, 1400-1700 hrs.) hold by Global Application Manager Dr. Rebekka Spellerberg in partnership with Stefano Biserni from IMA ACTIVE based in  Bologna, Italy.

MEGGLE will be additionally represented at RDD USA by the Head of R&D, Ricarda Leister, who commented: “We have a long-standing relationship with the RDD series as one of the leading events in the field of Dry Powder Inhalation. Those events are highly important for us to attend, both to demonstrate our expertise in the field of inhalation and also for the networking opportunities they create.”

About MEGGLE Wasserburg

The Bavarian-based company MEGGLE is one of the world’s experts in co-processing and powder technology. From its roots as a dairy operation in the late 1880’s, MEGGLE has become one of the world’s leading manufacturers of pharmaceutical lactose excipients, supplying the pharmaceutical industry with a broad-based and unique lactose product portfolio.

MEGGLE’s Business Unit Excipients has harnessed outstanding product quality and intelligent innovation to become a global leader in the manufacture of lactose-based excipients, focusing on products for direct tableting and dry powder inhalation.

A multidisciplinary team of committed and highly qualified people allows MEGGLE’s clients to benefit from pioneering experience and innovative drive in industrial milk and whey processing. The company constantly strives to develop high-technological and functional products for solid dosage forms and DPI applications, which deliver maximum performance.

The company has introduced several revolutionary products, notably Tablettose®, the world’s first agglomerated pharmaceutical lactose grade for direct tableting, Cellactose® 80, a pioneering co-processed excipient based on powdered cellulose and lactose monohydrate for outstanding compression and flow properties and RetaLac®, the first direct compressible co-processed excipient using Hypromellose and lactose monohydrate for sustained release formulations.

To learn more, visit: https://www.meggle-excipients.com/en/home.html

About RDD 2024

The Respiratory Drug Delivery (RDD) series of conferences impacts regulatory and scientific policies worldwide, and is recognized as one of the premier international meetings in this therapeutic area.

The success of the Respiratory Drug Delivery (RDD) Conference series is founded on the selection of internationally renowned speakers, lively audience participation, and the financial support of organizations with proven commitment in the field of inhalation.

The 2024 RDD USA international symposium devoted to issues surrounding nasal and pulmonary drug delivery is a five-day event, opening May 5 at the JW Marriott Starr Pass hotel in Tucson, Arizona, accompanied by an online dimension, RDD Online. The conference and co-located exhibition are expected to attract more than 1,000 participants.

The event is organized by RDD Online with further information at: https://www.rddonline.com/rdd/rdd.php?id=23&sid=12

Resources

Click on Highest quality for dry powder inhalation for further information.
Click on MEGGLE DPI technologies to view video.